PT - JOURNAL ARTICLE AU - van Klaveren, David AU - Rekkas, Alexandros AU - Alsma, Jelmer AU - Verdonschot, Rob JCG AU - Koning, Dick TJJ AU - Kamps, Marlijn JA AU - Dormans, Tom AU - Stassen, Robert AU - Weijer, Sebastiaan AU - Arnold, Klaas-Sierk AU - Tomlow, Benjamin AU - de Geus, Hilde RH AU - van Bruchem-Visser, Rozemarijn L AU - Miedema, Jelle R AU - Verbon, Annelies AU - van Nood, Els AU - Kent, David M AU - Schuit, Stephanie CE AU - Lingsma, Hester TI - COVID Outcome Prediction in the Emergency Department (COPE): Development and validation of a model for predicting death and need for intensive care in COVID-19 patients AID - 10.1101/2020.12.30.20249023 DP - 2021 Jan 01 TA - medRxiv PG - 2020.12.30.20249023 4099 - http://medrxiv.org/content/early/2021/02/08/2020.12.30.20249023.short 4100 - http://medrxiv.org/content/early/2021/02/08/2020.12.30.20249023.full AB - Background and aim COVID-19 is putting extraordinary pressure on emergency departments (EDs). To support decision making in the ED, we aimed to develop a simple and valid model for predicting mortality and need for intensive care unit (ICU) admission in suspected COVID-19 patients.Methods For model development, we retrospectively collected data of patients who were admitted to 4 large Dutch hospitals with suspected COVID-19 between March and August 2020 (first wave of the pandemic). Based on prior literature we considered quickly and objectively obtainable patient characteristics, vital parameters and blood test values as predictors. Logistic regression analyses with post-hoc uniform shrinkage was used to obtain predicted probabilities of in-hospital death and of the need for ICU admission, both within 28 days after hospital admission. We assessed model performance (Area Under the ROC curve (AUC); calibration plots) with temporal validation in patients who presented between September and December 2020 (second wave). We used multiple imputation to account for missing values.Results The development data included 5,831 patients, of whom 629 (10.8%) died and 5,070 (86.9%) were discharged within 28 days after admission. ICU admission was fully recorded for 2,633 first wave patients in 2 hospitals, with 214 (8%) ICU admissions within 28 days. A simple model – COVID Outcome Prediction in the Emergency Department (COPE) – with age, respiratory rate, C-reactive protein, lactic dehydrogenase, albumin and urea captured most of the ability to predict death. COPE was well-calibrated and showed good discrimination in 3,252 second wave patients (AUC in 4 hospitals: 0.82 [0.78; 0.86]; 0.82 [0.74; 0.90]; 0.79 [0.70; 0.88]; 0.83 [0.79; 0.86]). COPE was also able to identify patients at high risk of needing IC in 706 second wave patients with complete information on ICU admission (AUC: 0.84 [0.78; 0.90]; 0.81 [0.66; 0.95]). The models are implemented in web-based and mobile applications.Conclusion COPE is a simple tool that is well able to predict mortality and need for ICU admission for patients who present to the ED with suspected COVID-19 and may help patients and doctors in decision making.What is already known on this topicPrediction models have the potential to support decision making about hospital admission of patients presenting to the emergency department with suspected COVID-19Most currently available models that were independently assessed contain a high risk of biasPromising models were developed in different patient selections and included predictors that are not quickly and objective obtainable in emergency departmentsWhat this study addsA simple and objective tool (“COPE”) is well able to predict mortality and need for ICU admission for patients who present to the ED with suspected COVID-19COPE may support ED physicians to identify high-risk patients – i.e. those at high risk of deterioration and/or death – requiring treatment in the ICU, intermediate-risk patients requiring admission to the clinical ward, and low-risk patients who can potentially be sent homeCompeting Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by ZonMw (project number 10430 01 201 0019: Clinical prediction models for COVID-19: development, international validation and use) and the Patient-Centered Outcomes Research Institute (PCORI grant number ME-1606-35555: How Well Do Clinical Prediction Models (CPMs) Validate? A Large-Scale Evaluation of Cardiovascular Clinical Prediction Models).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The Daily Board of the Medical Ethics Committee Erasmus MC of Rotterdam, The Netherlands, has approved the research proposal (MEC-2020-0297).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAccording to data transfer agreements the data is not publicly available.